Corneal cross linking and infectious keratitis: A systematic review with a meta-analysis of reported cases

Journal of Ophthalmic Inflammation and Infection

Volumn 3, Issue 1, 2013, Pages 1-7

  Alio, Jorge L ^a,b   Abbouda, Alessandro ^a   Valle, David Diaz ^c   del Castillo, Jose M Benitez ^c   Fernandez, Jose A Gegundez ^c  

^a VISSUM Corporacion Oftalmologica   (Spain)

^b MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Collagen cross linking; Corneal melting; Infectious keratitis; UV A

Indexed keywords

RIBOFLAVIN;

ACANTHAMOEBA; ARTICLE; BACTERIAL KERATITIS; CORNEA TRANSPLANTATION; CROSS LINKING; EPITHELIZATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; KERATITIS; KERATOMYCOSIS; KERATOPLASTY; META ANALYSIS; PRIORITY JOURNAL; SYSTEMATIC REVIEW; ULTRAVIOLET A RADIATION;

EID: 84891454819     PISSN: None     EISSN: 18695760     Source Type: Journal    
DOI: 10.1186/1869-5760-3-47     Document Type: Article

References (48)

1. Keay L, Edwards K, Naduvilath T, Taylor HR, Snibson GR, Fordek SF (2006) Microbial keratitis predisposing factors and morbidity. Ophthalmology 113:109-116
2. Bourcier T, Thomas F, Borderie V, Chaumeil C, Laroche L (2003) Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases. Br J Ophthalmol 87:834-838
3. Wong T, Ormonde S, Gamble G, McGhee CN (2003) Severe infective keratitis leading to hospital admission in New Zealand. Br J Ophthalmol 87:1103-1108
4. McLeod SD, LaBree LD, Tayyanipour R, Flowers CW, Lee PP, McDonnell PJ (1995) The importance of initial management in the treatment of severe infectious corneal ulcers. Ophthalmology 102:1943-1948
5. Ibrahim YW, Boase DL, Cree IA (2009) Epidemiological characteristics, predisposing factors and microbiological profiles of infectious corneal ulcers: the Portsmouth corneal ulcer study. Br J Ophthalmol 93:1319-1324
6. Green M, Apel A, Stapleton F (2008) Risk factors and causative organisms in microbial keratitis. Cornea 27:22-27
7. Saeed A, D'Arcy F, Stack J, Collum LM, Power W, Beatty S (2009) Risk factors, microbiological findings, and clinical outcomes in cases of microbial keratitis admitted to a tertiary referral center in Ireland. Cornea 28:285-292
8. Jeng BH, Gritz DC, Kumar AB, Holsclaw DS, Porco TC, Smith SDWJP, Margolis TP, Wong IG (2010) Epidemiology of ulcerative keratitis in Northern California. Arch Ophthalmol 128:1022-1028
9. Jones DB (1981) Decision-making in the management of microbial keratitis. Ophthalmology 88:814-820
10. Bennett HGB, Hay J, Devonshire P, Kirkness CM, Seal DV (1998) Antimicrobial management of presumed microbial keratitis: guidelines for treatment of central and peripheral ulcers. Br J Ophthalmol 82:137-145
11. Neu HC (1992) The crisis in antibiotic resistance. Science 257:1064-1073
12. Bertino JS (2009) Impact of antibiotic resistance in the management of ocular infections: the role of current and future antibiotics. Clin Ophthalmol 3:507-521
13. Betanzos-Cabrera G, Juarez-Verdayes MA, Gonzalez-Gonzalez G, Cancino-Diaz ME, Cancino-Diaz JC (2009) Gatifloxacin, moxifloxacin, and balofloxacin resistance due to mutations in the gyrA and parC genes of Staphylococcus epidermidis strains isolated from patients with endophthalmitis, corneal ulcers and conjunctivitis. Ophthalmic Res 42:43-48
14. Wollensak G (2006) Crosslinking treatment of progressive keratoconus: new hope. Curr Opin Ophthalmol 17:356-360
15. Wollensak G, Spoerl E, Seiler T (2003) Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol 135:620-627
16. Tsugita A, Okada Y, Uchara K (1965) Photosensitized inactivation of ribonucleic acids in the presence of riboflavin. Biochim Biophys Acta 103:360-363
17. Goodrich RP (2000) The use of riboflavin for inactivation of pathogens in blood products. Vox Sang 78(suppl 2):211-215
18. McAteer MJ, Tay-Goodrich B, Doane S (2000) Photoinactivation of virus in packed red blood cell units using riboflavin and visible light. Transfusion 40(suppl):99S
19. Uc MH, Scott JF (1966) Effects of ultraviolet light on the biological functions of transfer RNA. Biochem Biophys Res Commun 22:459-465
20. Kumar V, Lockerbie O, Keil SD (2004) Riboflavin and UV-light based pathogen reduction: extent and consequence of DNA damage at the molecular level. Photochem Photobiol 80:15-21
21. Spoerl E, Wollensak G, Seiler T (2004) Increased resistance of crosslinked cornea against enzymatic digestion. Curr Eye Res 29:35-40
22. Schilde T, Kohlhaas M, Spoerl E (2008) Enzymatic evidence of the depth dependence of stiffening on riboflavin/UVA treated corneas [in German]. Ophthalmol 105:165-169
23. Anwar HM, El-Danasoury AM, Hashem AN (2011) Corneal collagen crosslinking in the treatment of infectious keratitis. Clin Ophthalmol 5:1277-1280
24. Makdoumi K, Mortensen J, Sorkhabi O, Malmvall BE, Crafoord S (2012) UVA-riboflavin photochemical therapy of bacterial keratitis: a pilot study. Graefes Arch Clin Exp Ophthalmol 50:95-102
25. Makdoumi K, Mortensen J, Crafoord S (2010) Infectious keratitis treated with corneal crosslinking. Cornea 29:1353-1358
26. Morén H, Malmsjö M, Mortensen J, Ohrström A (2010) Riboflavin and ultraviolet a collagen crosslinking of the cornea for the treatment of keratitis. Cornea 29:102-104
27. Iseli HP, Thiel MA, Hafezi F, Kampmeier J, Seiler T (2008) Ultraviolet A/ riboflavin corneal cross-linking for infectious keratitis associated with corneal melts. Cornea 27:590-594
28. Micelli Ferrari T, Leozappa M, Lorusso M, Epifani E, Micelli Ferrari L (2009) Escherichia coli keratitis treated with ultraviolet A/riboflavin corneal crosslinking: a case report. Eur J Ophthalmol 19:295-297
29. Khan YA, Kashiwabuchi RT, Martins SA, Castro-Combs JM, Kalyani S, Stanley P, Flikier D, Behrens A (2011) Riboflavin and ultraviolet light a therapy as an adjuvant treatment for medically refractive Acanthamoeba keratitis: report of 3 cases. Ophthalmology 118:324-331
30. Martins SA, Combs JC, Noguera G, Camacho W, Wittmann P, Walther R, Cano M, Dick J, Behrens A (2008) Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis. Invest Ophthalmol Vis Sci 49:3402-3408
31. Schrier A, Greebel G, Attia H, Trokel S, Smith EF (2009) In vitro antimicrobial efficacy of riboflavin and ultraviolet light on Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, and Pseudomonas aeruginosa. J Refract Surg 25:S799-S802
32. Makdoumi K, Backman A, Mortensen J, Crafoord S (2010) Evaluation of antibacterial efficacy of photo-activated riboflavin using ultraviolet light (UVA). Graefes Arch Clin Exp Ophthalmol 248:207-212
33. Schnitzler E, Sporl E, Seiler T (2000) Irradiation of cornea with ultraviolet light and riboflavin administration as a new treatment for erosive corneal processes, preliminary results in four patients. Klin Monbl Augenheilkd 217:190-193
34. Price MO, Tenkman LR, Schrier A, Fairchild KM, Trokel SL, Price FW Jr (2012) Photoactivated riboflavin treatment of infectious keratitis using collagen cross-linking technology. J Refract Surg 28:706-713
35. Panda A, Krishna SN, Kumar S (2012) Photo-activated riboflavin therapy of refractory corneal ulcers. Cornea 31:1210-1213
36. Sorkhabi R, Sedgipoor M, Mahdavifard A (2013) Collagen cross-linking for resistant corneal ulcer. Int Ophthalmol 33:61-66
37. Müller L, Thiel MA, Kipfer-Kauer AI, Kaufmann C (2012) Corneal cross-linking as supplementary treatment option in melting keratitis: a case series. Klin Monbl Augenheilkd 229:411-415
38. Skaat A, Zadok D, Goldich Y (2011) Riboflavin/UVA Photochemical therapy for severe infectious Keratitis. Paper presented at the American Academy of Ophthalmology. Annual Meeting, Orlando, Florida, pp 22-25
39. Higgins JPT, Green S (eds) (2008) Cochrane handbook for systematic reviews of interventions: cochrane book. The Cochrane Collaboration, Melbourne
40. Corbin F III (2002) Pathogen inactivation of blood components: current status and introduction of an approach using riboflavin as a photosensitizer. Int J Hematol 76(suppl 2):253-257
41. Schnitzler E, Spörl E, Seiler T (2000) Irradiation of cornea with ultraviolet light and riboflavin adminstration as a new treatment for erosive corneal processes, preliminary results in four patients. Klin Monbl 217(3):190-193
42. Wang F (2008) UVA/riboflavin-induced apoptosis in mouse cornea. Ophthalmologica 222:369-372
43. Takami Y, Gong H, Amemiya T (2004) Riboflavin deficiency induces ocular surface damage. Ophthalmic Res 36:156-165
44. Bertollo CM, Oliveira AC, Rocha LT (2006) Characterization of the antinociceptive and anti-inflammatory activities of riboflavin in different experimental models. Eur J Pharmacol 547:184-191
45. Xie L, Zhai H, Shi W (2007) Penetrating keratoplasty for corneal perforations in fungal keratitis. Cornea 26:158-162
46. Berra M, Galperín G, Boscaro G, Zarate J, Tau J, Chiaradia P, Berra A (2013) Treatment of Acanthamoeba keratitis by corneal cross-linking. Cornea 32:174-178
47. Zhang ZY (2013) Corneal cross-linking for the treatment of fungal keratitis. Cornea 32:217-218
48. Tschopp M, Stary J, Frueh BE et al (2012) Impact of corneal cross-linking on drug penetration in an ex vivo porcine eye model. Cornea 31:222-226